Early Research Reveals Key Player in Nonalcoholic Fatty Liver Disease

Metabolic dysfunction-associated steatotic liver disease (MASLD), a condition in which excess fat builds up in the liver, affects nearly one in four Americans, according to the National Institute of Diabetes and Digestive and Kidney Diseases. Incidence of MASLD, formerly known as nonalcoholic fatty liver disease, has more than doubled over the past 20 years, according to the American Liver Foundation. The more severe form of MASLD, when fat buildup in the liver is more than 5 to 10 percent, is known as metabolic dysfunction-associated steatohepatitis (MASH). With MASH (formerly referred to as nonalcoholic steatohepatitis, or NASH) on the rise, researchers are pushing to understand more about the factors that influence the disease.

Scientists at Duke-NUS Medical School in Singapore have zeroed in on an amino acid called homocysteine, which appears to cause inflammation in people with MASH. In a two-part study published July 8, 2022, in the Journal of Hepatology, researchers looked at whether supplementing the diet with folic acid and vitamin B12 could reverse inflammation.

According to Madhulika Tripathi, MD, a senior research fellow with the laboratory of hormonal regulation in Duke-NUS Medical School’s cardiovascular and metabolic program, who co-led the study, inflammation can cause MASH to progress into cirrhosis, which can lead to liver failure or liver cancer. Although scientists know that MASH is associated with elevated levels of homocysteine, they don’t know what role it plays in the disorder.

In the first part of the study, researchers used mice and humans to determine how homocysteine levels correlated with MASH. They found that higher levels of homocysteine, called hyperhomocysteinemia, were associated with MASH progression.

Leave a Reply

Your email address will not be published. Required fields are marked *